Pacer Advisors’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-509
Closed -$7.91K 2586
2024
Q2
$7.91K Sell
509
-1,189
-70% -$14.4K ﹤0.01% 3586
2024
Q1
$18K Buy
+1,698
New +$17K ﹤0.01% 3462
2021
Q2
Sell
-1,154
Closed -$79K 1436
2021
Q1
$79K Sell
1,154
-758
-40% -$58.9K ﹤0.01% 1323
2020
Q4
$139K Sell
1,912
-582
-23% -$33.7K ﹤0.01% 1296
2020
Q3
$95K Buy
+2,494
New +$84.2K ﹤0.01% 1255
2018
Q4
Sell
-2,456
Closed -$71K 620
2018
Q3
$71K Buy
+2,456
New +$46K ﹤0.01% 1123

Other funds holding CDNA

Pacer Advisors's CDNA Position: Q3 2024 in Review

Pacer Advisors sold out of CareDx (CDNA) in Q3 2024, closing a stake of 509 shares — an estimated $7.91K sold.

Pacer Advisors first reported a position in CDNA in Q3 2018 and held it in 6 quarters. The position peaked at $139K in Q4 2020. 215 funds tracked by Wall St. Rank hold CDNA as of Q3 2024.

  • Pacer Advisors reported no remaining CareDx position as of Q3 2024 after selling out during the quarter.
  • Pacer Advisors sold 509 CareDx shares in Q3 2024, an estimated $7.91K.
  • Pacer Advisors first reported a position in CareDx in Q3 2018 and held it in 6 quarters.
  • Pacer Advisors's CareDx position peaked at $139K in Q4 2020.
  • 215 funds tracked by Wall St. Rank held CareDx as of Q3 2024.

Based on Pacer Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.